Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


黑豹加速器永久免费版

July 31, 2025 - Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results July 7, 2025 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2025 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

黑豹加速器永久免费版

黑豹加速器永久免费版

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

黑豹加速器永久免费版

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
电脑免费节点  飞狗加速器官网  letsVPN官方下载  白狐加速器下载  快连vpn没有会员能用吗?  啊特加速器  黑洞hd18永久加速器